Thomas Stankovich - Dec 2, 2021 Form 4 Insider Report for ReShape Lifesciences Inc. (RSLS)

Role: Chief Financial Officer
Signature: /s/ Thomas Stankovich
Stock symbol: RSLS
Transactions as of: Dec 2, 2021
Transactions value $: -$7,863
Form type: 4
Date filed: 12/9/2021, 03:17 PM
Previous filing: Nov 18, 2021
Next filing: Jan 28, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RSLS	Common Stock, $0.001 par value per share	Sale	-$7.86K	-4.3K	-1.16%	$1.83	366K	Dec 2, 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were sold to cover taxes in connection with the vesting of restricted stock units.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.82 to $1.83, inclusive. The reporting person undertakes to provide to ReShape Lifesciences Inc., any security holder of ReShape Lifesciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Content

These shares were sold to cover taxes in connection with the vesting of restricted stock units.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.82 to $1.83, inclusive. The reporting person undertakes to provide to ReShape Lifesciences Inc., any security holder of ReShape Lifesciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.